Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -4.52%48.580.0%$723.51m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$392.53m
HZNPHorizon Therapeutics Plc 0.38%90.915.6%$195.15m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$188.22m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$142.45m
CTLTCatalent, Inc. 1.07%113.452.1%$115.04m
ICLRICON plc -2.04%180.684.2%$85.81m
ARGXargenx SE -2.59%330.680.0%$81.68m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$68.33m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.97m
PRGOPerrigo Co. Plc -1.64%40.116.8%$52.68m
AMRNAmarin Corp. Plc -3.02%6.741.5%$51.52m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$45.85m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$43.23m

Company Profile

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.